Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

An open ended Equity scheme replicating MSCI India Domestic & World Healthcare 45 Index

Data as on 31st August, 2024
Investment Objective :
The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Inception Date 26-Oct-2020
Benchmark MSCI India Domestic & World Healthcare 45 Index
Fund Managers Details Mr. Bhavesh Jain Experience 16 years Managing Since 01-Oct-2021
Mr. Amit Vora (for investments in foreign securities) Experience 16 years Managing Since 12-Feb-2021
Minimum Investment Amount Minimum of Rs. 100/-‐ and multiples of Re. 1/- thereafter.
Additional investment amount Minimum of Rs. 100/- and multiples of Re. 1/- thereafter.
Plan/Options Direct and Regular Plan with Growth and IDCW Reinvestment, Payout & Sweep
Exit Load NIL
Total Expense Ratios~ Regular 1.03%
Direct 0.50%
Tracking Error:
Regular: 0.89%
Tracking error is annualised and is calculated based on data since inception.
Month End AUM `
Rs. 159.58 Crore
Monthly Average AUM
Rs. 151.92 Crore

NAV

Regular Plan - Growth
20.1127
Regular Plan - IDCW
20.1127
Direct Plan - Growth
20.5657
Direct Plan - IDCW
20.5657
(as on August 30, 2024)  
Name of Instrument
Industry
% to Net Assets
Equities 99.86%
SUN PHARMACEUTICAL INDUSTRIES LTD Healthcare 13.72%
CIPLA LTD Healthcare 6.77%
DR. REDDY'S LABORATORIES LTD Healthcare 6.51%
APOLLO HOSPITALS ENTERPRISES LTD Healthcare 5.44%
MAX HEALTHCARE INSTITUTE LIMITED Healthcare 5.22%
ELI LILLY & CO Pharmaceuticals 5.21%
DIVI'S LABORATORIES LTD Healthcare 4.70%
LUPIN LTD Healthcare 3.99%
AUROBINDO PHARMA LTD Healthcare 3.24%
NOVO-NORDISK A/S-SPONS ADR MISCELLANEOUS 3.03%
TORRENT PHARMACEUTICALS LTD Healthcare 2.73%
JOHNSON & JOHNSON Pharmaceuticals 2.68%
ABBVIE INC Biotechnology 2.35%
FORTIS HEALTHCARE LTD Healthcare 2.14%
MERCK & CO. INC. Pharmaceuticals 2.01%
MANKIND PHARMA LTD. Healthcare 1.97%
GLENMARK PHARMACEUTICALS LTD Healthcare 1.95%
NOVARTIS AG - SPONSORED ADR Pharmaceuticals 1.61%
THERMO FISHER SCIENTIFIC INC Healthcare 1.59%
IPCA LABORATORIES LTD Healthcare 1.55%
ABBOTT LABORATRIES Health Care Equipment 1.33%
LAURUS LABS LIMITED Healthcare 1.29%
DANAHER CORP Healthcare 1.27%
SYNGENE INTERNATIONAL LTD Healthcare 1.20%
AMGEN INC Healthcare 1.20%
BIOCON LTD Healthcare 1.18%
INTUITIVE SURGICAL INC Healthcare 1.17%
GLAND PHARMA LIMITED Healthcare 1.09%
J. B. CHEMICALS & PHARMA LTD Healthcare 1.07%
AJANTA PHARMA LTD Healthcare 1.06%
DR. LAL PATH LABS LTD Healthcare 1.01%
GLAXOSMITHKLINE PHARMACEUTICALS LTD Healthcare 0.95%
SUVEN PHARMACEUTICALS LTD Healthcare 0.87%
VERTEX PHARMACEUTICAL - COM STK USD0.01 Healthcare 0.86%
STRYKER CORP Healthcare 0.84%
MEDTRONIC PLC Healthcare 0.79%
NARAYANA HRUDAYALAYA LTD Healthcare 0.71%
GLOBAL HEALTH LTD. Healthcare 0.69%
GILEAD SCIENCES INC - COM USD0.001 (CLP) Biotechnology 0.67%
PFIZER LTD Healthcare 0.65%
BECTON DICKINSON AND CO Healthcare 0.47%
IQVIA HOLDINGS INC Healthcare 0.31%
AGILENT TECHNOLOGIES INC Healthcare 0.28%
SANOFI CONSUMER HEALTHCARE INDIA LIMITED Healthcare 0.21%
MODERNA INC - COM USD0.0001 Pharmaceuticals 0.17%
ILLUMINA INC Healthcare 0.14%
GRAIL INC - COM USD0.001 WI Healthcare 0.00%
Cash & Other Receivables 0.14%
TREPS_RED_02.09.2024   0.28%
Cash & Cash Equivalent   -0.15%
Grand Total 100.00%
Period
Scheme - Regular Plan
Benchmark
(MSCI India Domestic & World Healthcare 45 Index#)
Additional Benchmark
(Nifty 50 TR Index)
Returns*
Value of Rs. 10000
Invested
Returns*
Value of Rs. 10000
Invested
Returns*
Value of Rs. 10000
Invested
1 Year
42.47%
14,247
43.84%
14,384
32.64%
13,264
3 Years
15.53%
15,421
15.39%
15,365
15.17%
15,274
Since Inception - Regular Plan
19.92%
20,113
20.37%
20,402
23.42%
22,469

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments.
Notes:
1. The performance details provided herein are of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund. Since Inception returns are calculated on Rs. 10/- invested at inception. In case the start/end date is non business day, the NAV of previous day is used for computation.
2.The scheme is currently managed by Bhavesh Jain (managing this fund from October 01, 2021) and Amit Vora (managing this fund from February 12, 2021) Click here for name of the other schemes currently managed by the Fund Managers and relevant scheme for performance.

Disclaimer of MSCI: MSCI Inc. (“MSCI”), is the Index Service Provider. MSCI has been formed with the objective of providing a variety of indices and index related services and products for the capital market. MSCI India Domestic & World Healthcare 45 Index, the underlying index for the Scheme, has been licensed from MSCI. MSCI India Domestic & World Healthcare 45 Index, is a public Index. The index values are calculated by MSCI on daily basis and put up on the MSCI website https://www.msci.com/index country membership tool.

Disclaimer of NSE: It is to be distinctly understood that the permission given by NSE should not in any way be deemed or construed that the Scheme Information Document has been cleared or approved by NSE nor does it certify the correctness or completeness of any of the contents of the Scheme Information Document. The investors are advised to refer to the Scheme Information Document for the full text of the 'Disclaimer Clause of NSE'. The “Product” offered by “the issuer” is not sponsored, endorsed, sold or promoted by NSE (formerly known as India Index Services & Products Limited (IISL)). NSE does not make any representation or warranty, express or implied (including warranties of merchantability or fitness for particular purpose or use) and disclaims all liability to the owners of “the Product” or any member of the public regarding the advisability of investing in securities generally or in “the Product” linked to MSCI India Domestic & World Healthcare 45 Index or particularly in the ability of the MSCI India Domestic & World Healthcare 45 Index to track general stock market performance in India. Please read the full Disclaimers in relation to the MSCI India Domestic & World Healthcare 45 Index in the in the Scheme Information Document.

This Product is suitable for investors who are seeking*:

  • Long term capital appreciation
  • Passive investment in equity and equity related securities replicating the composition of MSCI India Domestic & World Healthcare 45 Index, subject to tracking errors

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Riskometer

Investors understand that their principal will be at Very High Risk

Benchmark Riskometer: MSCI India Domestic
& World Healthcare 45 Index

Investors understand that their principal will be at Very High Risk